Results 71 to 80 of about 21,010 (265)

Serosal overturning assisted endoscopic full‐thickness mucosal resection of extraneous giant mass at the esophagogastric junction

open access: yesClinical Case Reports
Key Clinical Message Serosal overturning assisted endoscopic full‐thickness mucosal resection was performed on the extraneous giant masses at the esophagogastric junction without complications.
Shumin Qin   +3 more
doaj   +1 more source

Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction

open access: yesFrontiers in Genetics, 2022
Background: From previous studies, we found that there are more than 100 types of RNA modifications in RNA molecules. m6A methylation is the most common.
Jia-Bin Huang   +6 more
doaj   +1 more source

Esophagogastric junction distensibility identifies achalasia subgroup with manometrically normal esophagogastric junction relaxation

open access: yesNeurogastroenterology & Motility, 2016
AbstractBackgroundManometric criteria to diagnose achalasia are absent peristalsis and incomplete relaxation of the esophagogastric junction (EGJ), determined by an integrated relaxation pressure (IRP) >15 mm Hg. However, EGJ relaxation seems normal in a subgroup of patients with typical symptoms of achalasia, no endoscopic abnormalities, stasis on ...
Ponds, F. A.   +3 more
openaire   +2 more sources

Risk Factors for Anastomotic Stricture and Obstructive Symptoms Following Double‐Flap Technique Reconstruction After Proximal Gastrectomy

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This retrospective study investigated risk factors for anastomotic stricture and obstructive symptoms following double‐flap technique (DFT) reconstruction after proximal gastrectomy. Mucosal detachment, potentially caused by thermal damage, was identified as a significant risk factor for anastomotic stricture, while continuous suturing at the esophago ...
Shinji Kuroda   +9 more
wiley   +1 more source

Impaired Esophageal Motility and Clearance Post-Lung Transplant: Risk For Chronic Allograft Failure [PDF]

open access: yes, 2017
Objectives: Gastroesophageal reflux is common in patients post-lung transplantation (LTx) and thus considered a risk factor for aspiration and consequently allograft rejection and the development of chronic allograft failure. However, evidence supporting
Almansa   +30 more
core   +1 more source

Short‐ and Long‐Term Outcomes of Subtotal Gastrectomy for Remnant Gastric Cancer: A Multicenter Study

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This multicenter study compared subtotal versus completion gastrectomy for remnant gastric cancer. Subtotal gastrectomy was associated with shorter operative time and significantly less postoperative weight loss, with no difference in long‐term survival, suggesting it as a feasible surgical option without compromising oncologic outcomes.
Kensuke Kudou   +9 more
wiley   +1 more source

Peroral endoscopic myotomy (POEM) for treating esophageal motility disorders [PDF]

open access: yes, 2017
Review Article on Endoscopic Therapy© Annals of Translational Medicine. All rights reserved. Pneumatic dilatation and Heller myotomy have been thoroughly studied as the most viable treatment options for achalasia.
Law, SYK, Wong, YHI
core   +1 more source

Macroscopic and histomorphometric analysis of the esophagogastric junction region of horses used for traction [PDF]

open access: yesBiotemas, 2011
The esophagogastric junction was evaluated macroscopically and histologically, seeking to identify adaptive changes in a sample of six adult horses, being four males and two females, used for traction.
Eduardo Maurício Mendes de Lima   +5 more
doaj  

Efficacy and safety of fruquintinib combined with albumin‐bound paclitaxel as second‐line therapy for advanced gastric cancer following failure of PD‐1 inhibitor‐containing treatment (TACTIC GC‐01): A phase II single‐arm study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Anti‐angiogenic drugs have shown promising efficacy as a second‐line treatment for advanced gastric cancer. However, it remains unclear how alterations in the tumor microenvironment following first‐line immunotherapy may impact tumor angiogenesis and influence subsequent therapeutic outcomes. This single‐arm study prospectively explored the
Xiaoting Ma   +11 more
wiley   +1 more source

Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study [PDF]

open access: yes, 2017
Background: The optimal duration of firstline chemotherapy in metastatic esophagogastric cancer is unknown. In most clinical trials therapy was given until tumour progression or limiting toxicity.
Haag, Georg-Martin   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy